Whitepapers/App Notes/Posters

Whitepaper: The Use of Positron Emission Tomography (PET) in Pre-clinical Pharmaceutical Research

Posted: 30 August 2019 | | No comments yet

Positron emission tomography (PET) is a popular nuclear imaging technique used to gain information about specific metabolic functions.

Used in clinical diagnostic and pre-clinical applications, PET is often combined with other imaging technologies, such as magnetic resonance imaging (MRI) and computed tomography (CT) scanning, to incorporate anatomical information. PET provides functional imaging, which shows the spatial distribution of biomolecular activity in living tissues and is therefore particularly useful for evaluating drug candidates in pre-clinical studies.











To read this Whitepaper in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


*

*

*

*

*

*

*

*

This content is provided to you for free thanks to the kind support of our sponsor: Bruker

Send this to a friend